| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/01/2004 | WO2003088927A3 Novel curcumin analogues and uses thereof |
| 04/01/2004 | WO2003086412A3 Polyphosphonate derivatives for toothpaste compositions |
| 04/01/2004 | WO2003084965A8 N-(3-rifamycinyl)-carbamates, method of preparing them and their use for treating and preventing tuberculosis |
| 04/01/2004 | WO2003084943A3 Terphenyl derivatives, preparation thereof, compositions containing same |
| 04/01/2004 | WO2003084517A3 Oral suspension of amoxicillin capsules |
| 04/01/2004 | WO2003082926A3 Antimicrobial polymer conjugates |
| 04/01/2004 | WO2003081238A3 Cytocapacity test |
| 04/01/2004 | WO2003075834A3 Activated protein c formulations |
| 04/01/2004 | WO2003070886A3 Inhibition of protein tyrosine phosphatase type iva expression byshort interfering nucleic acid |
| 04/01/2004 | WO2003067221A3 Compositions and methods for restoring immune responsiveness in patients with immunological defects |
| 04/01/2004 | WO2003066021A3 Drug nanoparticles with lysozyme surface stabiliser |
| 04/01/2004 | WO2003063792A3 Compositions and methods related to tim-3, a th1-specific cell surface molecule |
| 04/01/2004 | WO2003063770A3 Expression vectors encoding epitopes of target-associated antigens and methods for their design |
| 04/01/2004 | WO2003060090A3 Novel cytokine zcytor17 ligand |
| 04/01/2004 | WO2003049675A3 Treating muscle wasting with selective androgen receptor modulators |
| 04/01/2004 | WO2003048186A3 Surface simulation synthetic peptides useful in the treatment of hyper-variable viral pathogens |
| 04/01/2004 | WO2003031940A3 Structural and cytoskeleton-associated proteins |
| 04/01/2004 | WO2003012044A9 Hagfish cathelin-associated antimicrobial peptides and genes |
| 04/01/2004 | WO2003009842A8 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same |
| 04/01/2004 | WO2003008410A8 Polypyrroles as agents for treating cancer, treating viral diseases and causing immunosuppression |
| 04/01/2004 | WO2002095417A3 PRE-mRNA SPLICING SCREENING ASSAY |
| 04/01/2004 | WO2002085897A9 Heterocyclic compounds for aging-related and diabetic vascular complications |
| 04/01/2004 | WO2002076402A3 Fatty amine drug conjugates |
| 04/01/2004 | WO2002060485A9 Use of immunoregulatory antibodies in the treatment of neoplastic disorders |
| 04/01/2004 | US20040063948 Crystalline fluoroquinolone arginine salt form |
| 04/01/2004 | US20040063944 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives |
| 04/01/2004 | US20040063916 Bactericides; antibiotics |
| 04/01/2004 | US20040063913 Antibodies to human il-1beta |
| 04/01/2004 | US20040063908 Comprises genetically engineered hemophilus adherence and penetration (HAP) proteins for treatment and prevention of influenza; immunotherapy |
| 04/01/2004 | US20040063906 Peptide nucleic acid sequences; antibodies for controlling disease; bactericides, viricides |
| 04/01/2004 | US20040063785 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use |
| 04/01/2004 | US20040063781 Compounds active at the glucocorticoid receptor II |
| 04/01/2004 | US20040063771 Bis-sulfonamide hydroxyethyl-amino retroviral protease inhibitors |
| 04/01/2004 | US20040063759 Administering to a mammal, for treatment or prevention of conditions that can be treated or prevented by antagonizing the CCR1 receptor in a mammal, a piperidinone compound |
| 04/01/2004 | US20040063745 2-amino-4-(pyridin-2-yl)-thiazole derivatives as transforming growth factor beta (tgf-beta) inhibitors |
| 04/01/2004 | US20040063743 Preparation of 1H-imidazo [4,5-C] quinolin-4-amines via novel 1H-imidazo [4,5-c] quinolin-4-cyano and 1H-imidazo [4,5-c] quinolin-4-carboxamide intermediates |
| 04/01/2004 | US20040063734 4,4-Disubstituted-3,4-dihydro-2 (1H)-quinazoliniones useful as HIV reverse transcriptase inhibitors |
| 04/01/2004 | US20040063732 Such as trans-N2-(4-aminocyclohexyl)-N6-(2-aminoethyl)-1H-purine-2,6-diamine trihydrochloride for treatment/prevention of fungal diseases |
| 04/01/2004 | US20040063722 Antifungal ketoconazole composition for topical use |
| 04/01/2004 | US20040063720 Tyrosine kinase inhibitors |
| 04/01/2004 | US20040063718 Targeted therapeutics and uses thereof |
| 04/01/2004 | US20040063716 Cholesterol biosynthesis inhibitors containing as the active ingredient tricyclic spiro compounds |
| 04/01/2004 | US20040063709 Acute and chronic inflammatory disorders; cancer |
| 04/01/2004 | US20040063707 Azaindole kinase inhibitors |
| 04/01/2004 | US20040063688 CCR1 receptor antagonists; such as 5-chloro-2-(2-(-3-(4-fluoro-phenoxy)-8-aza-bicyclo(3.2.1)oct-8-yl)-2-oxo -ethoxy)-benzamide |
| 04/01/2004 | US20040063687 Cardiac arrhythmias; potassium channel function inhibitors; such as 7-(3,4-Dichlorophenyl)-6-(5-fluoro-1-methyl-1H-benzimidazol-2-yl)-4,7 -dihydro-5-(methoxymethyl)pyrazolo-(1,5-a)pyrimidine |
| 04/01/2004 | US20040063685 Cycloalkene antisepsis drug with antibacterial, antifungal, nonsteroidal antiinflammatory, steroid and/or anticoagulant agents |
| 04/01/2004 | US20040063683 Novel carbapenem compounds |
| 04/01/2004 | US20040063677 Omega monounsaturated fatty acid derivativatized biologically active materials; drug delivery; drug resistance; bioavail-ability |
| 04/01/2004 | US20040063674 Tetracycline compounds having target therapeutic activities |
| 04/01/2004 | US20040063668 Antiviral agent; hepatitis B; such as ((1-((6-amino-9H-purin-9-yl)methyl)cyclopropyl)oxy)methylphosphonic acid |
| 04/01/2004 | US20040063658 Such as 9-(2'-C-methyl-beta-D-ribofuranosyl)-6-bromopurine |
| 04/01/2004 | US20040063651 3'-deoxy-3'-fluorouridine and 1-(3'-deoxy-fluoro-beta-ribofuranosyl)-uracil derivatives; reduced side effects; selectively inhibits viral RNA dependent RNA polymerase |
| 04/01/2004 | US20040063649 Azithromycin combination for emesis control in mammals |
| 04/01/2004 | US20040063647 Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors |
| 04/01/2004 | US20040063644 Urea and urethane derivatives as integrin inhibitors |
| 04/01/2004 | US20040063632 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants |
| 04/01/2004 | US20040063625 Cyclic peptide |
| 04/01/2004 | US20040063623 Formulation of boronic acid compounds |
| 04/01/2004 | US20040063622 Methods and compositions for treating flaviviruses and pestiviruses |
| 04/01/2004 | US20040063605 Contacting sample containing Urokinase-type plasminogen activator (UPA) with an antibody or a labelled antibody; determining amount of antibody or labelled antibody bound to uPA-R, antibody being specific for Mo3 (glycoprotein) |
| 04/01/2004 | US20040063095 gM-negative EHV-mutants |
| 04/01/2004 | US20040062818 Composition of hypochlorous acid and its applications |
| 04/01/2004 | US20040062777 Genetic engineered polypeptides; enzyme inhibitors |
| 04/01/2004 | US20040062774 Multiple epitope immunoglobulin for prevention and/or treatment of mastitis; bactericides |
| 04/01/2004 | US20040062762 Method of sterilizing antibody-containing milk and products containing sterilized antibody-containing milk |
| 04/01/2004 | US20040062754 Photopheresis treatment of chronic HCV infections |
| 04/01/2004 | US20040062744 Mixture of microbiocide and cationic polymer |
| 04/01/2004 | US20040062724 Thin, flexible, multilayer film; applying, adhesion to teeth; supplying active materials |
| 04/01/2004 | CA2499897A1 Use of posaconazole for the treatment of fungal infections |
| 04/01/2004 | CA2499701A1 Pyrrole derivatives as antimycobacterial compounds |
| 04/01/2004 | CA2499265A1 Inhibitor of hepatitis c viruses comprising, as the active ingredient, alpha-glycosylceramide |
| 04/01/2004 | CA2498662A1 Phenol derivatives and their use as rotamase inhibitors |
| 04/01/2004 | CA2498325A1 Prophylactic and therapeutic hiv aptamers |
| 04/01/2004 | CA2497903A1 Triazaspiro[5.5]undecane derivatives and drugs comprising the same as the active ingredient |
| 04/01/2004 | CA2497878A1 Improvements in or relating to vaccines |
| 04/01/2004 | CA2496386A1 Sorbicillactone-a derivatives for the treatment of tumour and viral diseases |
| 04/01/2004 | CA2495744A1 Non-nucleoside reverse transcriptase inhibitors |
| 03/31/2004 | EP1403643A1 Lawsonia intracellularis cultivation, anti-lawsonia intracelluaris vaccines and diagnostic agents |
| 03/31/2004 | EP1403375A2 Recombinant live avian vaccin, using avian herpes virus as vector |
| 03/31/2004 | EP1403285A1 Fibroblast growth factor receptors |
| 03/31/2004 | EP1403284A1 HAb18G/CD147, IT'S AGONIST AND APPLICATION |
| 03/31/2004 | EP1403270A1 Pde iv inhibitors |
| 03/31/2004 | EP1403269A1 Remedial agent for viral infectious disease |
| 03/31/2004 | EP1403255A1 Rho KINASE INHIBITORS |
| 03/31/2004 | EP1403252A1 Novel butadiene derivatives, process for preparation of the same and intermediates for the synthesis thereof |
| 03/31/2004 | EP1402903A1 Method of transporting physiological polymer using protein having rxp repeated sequence |
| 03/31/2004 | EP1402899A1 Remedies for sepsis |
| 03/31/2004 | EP1402897A2 Novel indications of Mannan-binding lectin (MBL) in the treatment of immunocompromised individuals |
| 03/31/2004 | EP1402888A1 The use of substituted carbocyclic compounds as rotamases inhibitors |
| 03/31/2004 | EP1402267A1 Chp for use as marker for sepsis-type inflammatory diseases |
| 03/31/2004 | EP1402066A2 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels |
| 03/31/2004 | EP1402064A2 Protein arrays and methods and systems for producing the same |
| 03/31/2004 | EP1402054A1 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 03/31/2004 | EP1402050A2 Methods for the recombinant production of peptidic antiviral fusion inhibitors, and acetylation of gp41 fragments |
| 03/31/2004 | EP1402040A2 A novel intein and uses thereof |
| 03/31/2004 | EP1402039A1 MUTANT FORMS OF EtxB AND CtxB AND THEIR USE AS CARRIERS |
| 03/31/2004 | EP1402032A1 Bcl-2-modifying factor (bmf) sequences and their use in modulating apoptosis |
| 03/31/2004 | EP1402019A1 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes |
| 03/31/2004 | EP1402018A1 Unigene unidirectional antisense library |